Document Detail


Cerebral atrophy and long-term response to levodopa in Parkinson's disease.
MedLine Citation:
PMID:  93625     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In 92 parkinsonian patients (42 men, 50 women) aged from 37-79 years (mean 62.8) the impact of cerebral atrophy as assessed by computed tomography on the course of the clinical symptomatology under levodopa during a period of 1 to 5 years was investigated. It could be shown that patients suffering from medium to severe degrees of atrophy-independent of its special location--have a less favorable response than those with normal CT findings. The data do not allow a definite decision whether cortical artrophy or ventricular enlargement are of major importance. At any rate, the width of the third ventricle seems to have no influence on the course of the clinical symptoms. After 3 years of levodopa treatment a dissociation between cerebral atrophy and therapeutic effectiveness can be observed.
Authors:
E Schneider; P A Fischer; P Jacobi; H Becker; M Beyer
Related Documents :
21324095 - The role of pde5 inhibitors in penile septal scar remodeling: assessment of clinical an...
20298985 - Primary transcatheter patent foramen ovale closure is effective in improving migraine i...
21257255 - De novo urgency after tension-free vaginal tape versus transobturator tape procedure fo...
19817885 - Expanding access to triptans: assessment of clinical outcome.
17919545 - Oral garenoxacin in the treatment of acute bacterial maxillary sinusitis: a phase ii, m...
21839245 - Primary immunosuppression and outcome differences after heart transplantation: tacrolim...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of neurology     Volume:  222     ISSN:  0340-5354     ISO Abbreviation:  J. Neurol.     Publication Date:  1979  
Date Detail:
Created Date:  1980-04-17     Completed Date:  1980-04-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0423161     Medline TA:  J Neurol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  37-43     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Atrophy
Brain / pathology*
Cerebral Cortex / pathology,  radiography
Cerebral Ventricles / pathology
Female
Follow-Up Studies
Humans
Levodopa / therapeutic use*
Male
Middle Aged
Parkinson Disease / drug therapy*
Prognosis
Time Factors
Tomography, X-Ray Computed
Chemical
Reg. No./Substance:
0/Levodopa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Treatment of myasthenia gravis. Report on 139 patients.
Next Document:  The prognosis of intraventricular hemorrhage.